The Brutal Math Behind the NervGen Spinal Injury Hype
A new drug offers hope for spinal cord injury recovery.
Tag: drug-development
Can Najat Khan Salvage the Recursion Map Before the Cash Runs Dry?
Recursion Pharmaceuticals undergoes a leadership change amid AI challenges.